Evidence map›Paper›PMID 40861566›Full record

ArticleCureus2025

Autoimmune Polyglandular Syndrome Type 3 and Overlapping Autoimmune Endocrinopathies: A Case Report.

Divyashri R Nagarajan, Daya Mani Jacob, Niyas Khalid Ottu Para

Abstract readCase Reports
In one paragraph

Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Divyashri R NagarajanInternal Medicine, Burjeel Medical City, Abu Dhabi, ARE.
Daya Mani JacobInternal Medicine, Burjeel Medical City, Abu Dhabi, ARE.
Niyas Khalid Ottu ParaInternal Medicine, Burjeel Medical City, Abu Dhabi, ARE.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Autoimmune polyglandular syndrome type 3 (APS type 3) is defined by the coexistence of autoimmune thyroid disease with other autoimmune disorders, excluding adrenal insufficiency. It is a common but often under-recognized entity, particularly in young women with multiple autoimmune conditions. We report the case of a 27-year-old woman with a longstanding history of type 1 diabetes mellitus (T1DM) who presented with multiple episodes of diabetic ketoacidosis to the emergency department. She presented with fatigue and had poor glycemic control (HbA1c 11.3%). She was further diagnosed in the ward with refractory autoimmune hypothyroidism, pernicious anemia, celiac disease with poor dietary adherence, and proliferative diabetic retinopathy requiring retinal intervention. Physical examinations, blood workup, and radiological investigations revealed no signs of adrenal insufficiency or pituitary adenoma. The combination of autoimmune thyroid disease, T1DM, pernicious anemia, celiac disease, and systemic autoimmunity, in the absence of adrenal involvement, is consistent with a diagnosis of APS type 3 with overlapping subtypes. This case illustrates the clinical complexity and diagnostic challenges of APS type 3. Early identification and multidisciplinary management of coexisting autoimmune disorders are essential for improving long-term outcomes and reducing complications. Attention to dietary adherence, appropriate thyroid hormone dosing, and ongoing screening for evolving autoimmune involvement are critical elements in the care of such patients.

Indexed as

autoimmune polyglandular syndrome type 3autoimmune thyroiditisendocrine dysfunctionlevothyroxine resistancemultiple autoimmune syndrome

Identifiers

PMID40861566
PMCPMC12372412

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.